Microcell-mediated chromosome transfer identifies EPB41L3 as a functional suppressor of epithelial ovarian cancers.

Journal article


Dafou, Dimitra, Grun, Barbara, Sinclair, Jonathan, Lawrenson, Kate, Benjamin, Elizabeth C., Hogdall, Estrid, Kruger-Kjaer, Susanne, Christensen, Lise, Sowter, Heidi M., Al-Attar, Ahmed, Edmondson, Richard, Darby, Stephen, Berchuck, Andrew, Laird, Peter W., Pearce, C. Leigh, Ramus, Susan J., Jacobs, Ian J. and Gayther, Simon A. 2010. Microcell-mediated chromosome transfer identifies EPB41L3 as a functional suppressor of epithelial ovarian cancers. Neoplasia (New York, N.Y.).
AuthorsDafou, Dimitra, Grun, Barbara, Sinclair, Jonathan, Lawrenson, Kate, Benjamin, Elizabeth C., Hogdall, Estrid, Kruger-Kjaer, Susanne, Christensen, Lise, Sowter, Heidi M., Al-Attar, Ahmed, Edmondson, Richard, Darby, Stephen, Berchuck, Andrew, Laird, Peter W., Pearce, C. Leigh, Ramus, Susan J., Jacobs, Ian J. and Gayther, Simon A.
Abstract

We used a functional complementation approach to identify tumor-suppressor genes and putative therapeutic targets for ovarian cancer. Microcell-mediated transfer of chromosome 18 in the ovarian cancer cell line TOV21G induced in vitro and in vivo neoplastic suppression. Gene expression microarray profiling in TOV21G(+18) hybrids identified 14 candidate genes on chromosome 18 that were significantly overexpressed and therefore associated with neoplastic suppression. Further analysis of messenger RNA and protein expression for these genes in additional ovarian cancer cell lines indicated that EPB41L3 (erythrocyte membrane protein band 4.1-like 3, alternative names DAL-1 and 4.1B) was a candidate ovarian cancer-suppressor gene. Immunoblot analysis showed that EPB41L3 was activated in TOV21G(+18) hybrids, expressed in normal ovarian epithelial cell lines, but was absent in 15 (78%) of 19 ovarian cancer cell lines. Using immunohistochemistry, 66% of 794 invasive ovarian tumors showed no EPB41L3 expression compared with only 24% of benign ovarian tumors and 0% of normal ovarian epithelial tissues. EPB41L3 was extensively methylated in ovarian cancer cell lines and primary ovarian tumors compared with normal tissues (P = .00004), suggesting this may be the mechanism of gene inactivation in ovarian cancers. Constitutive reexpression of EPB41L3 in a three-dimensional multicellular spheroid model of ovarian cancer caused significant growth suppression and induced apoptosis. Transmission and scanning electron microscopy demonstrated many similarities between EPB41L3-expressing cells and chromosome 18 donor-recipient hybrids, suggesting that EPB41L3 is the gene responsible for neoplastic suppression after chromosome 18 transfer. Finally, an inducible model of EPB41L3 expression in three-dimensional spheroids confirmed that reexpression of EPB41L3 induces extensive apoptotic cell death in ovarian cancers.

KeywordsApoptosis; Cell culture techniques; Cells, cultured; Chromosomes, Human, Pair 18; Female; Gene expression profiling; Gene expression regulation, neoplastic; Gene transfer techniques; Genes, tumor suppressor; Genetic association studies; Humans; Hybrid cells; Membrane proteins; Microarray analysis; Microfilament proteins; Neoplasms, glandular and epithelial; Ovarian neoplasms; Spheroids, cellular; Tumor suppressor proteins
Year2010
JournalNeoplasia (New York, N.Y.)
ISSN1476-5586
Web address (URL)http://hdl.handle.net/10545/252992
hdl:10545/252992
Publication datesJul 2010
Publication process dates
Deposited21 Nov 2012, 12:58
Rights

Archived with thanks to Neoplasia (New York, N.Y.)

ContributorsUniversity College London, EGA Institute for Women's Health, Gynaecological Cancer Research Laboratories
File
File Access Level
Open
Permalink -

https://repository.derby.ac.uk/item/95026/microcell-mediated-chromosome-transfer-identifies-epb41l3-as-a-functional-suppressor-of-epithelial-ovarian-cancers

Download files

  • 22
    total views
  • 0
    total downloads
  • 0
    views this month
  • 0
    downloads this month

Export as

Related outputs

The PAX8 cistrome in epithelial ovarian cancer.
Adler, Emily K., Corona, Rosario I., Lee, Janet M., Rodriguez-Malave, Norma, Mhawech-Fauceglia, Paulette, Sowter, Heidi M., Hazelett, Dennis J., Lawrenson, Kate and Gayther, Simon A. 2017. The PAX8 cistrome in epithelial ovarian cancer. Oncotarget. https://doi.org/10.18632/oncotarget.22718
Targeting Src in endometriosis-associated ovarian cancer
Manek, Roxanne, Pakzamir, Elham, Mhawech-Fauceglia, Paulette, Pejovic, Tanja, Sowter, Heidi M., Gayther, Simon A. and Lawrenson, Kate 2016. Targeting Src in endometriosis-associated ovarian cancer. Oncogenesis. https://doi.org/10.1038/oncsis.2016.54
Pilot study : can inspiratory muscle training relieve symptoms ff dyspnoea and improve quality of life for advanced cancer patients ?: 1872 Board #24 June 2, 3: 30 PM - 5: 00 PM.
Lindley, Martin R., Faghy, Mark, Sowter, Heidi M. and Mickleborough, Timothy D. 2016. Pilot study : can inspiratory muscle training relieve symptoms ff dyspnoea and improve quality of life for advanced cancer patients ?: 1872 Board #24 June 2, 3: 30 PM - 5: 00 PM. Wolters Kluwer. https://doi.org/10.1249/01.mss.0000486545.72377.ea
"I'm 100% for it! I'm a convert!" Women's experiences of a yoga programme during treatment for gynaecological cancer; an interpretative phenomenological analysis
Archer, Stephanie, Phillips, Elly, Montague, Jane, Bali, Anish and Sowter, Heidi M. 2014. "I'm 100% for it! I'm a convert!" Women's experiences of a yoga programme during treatment for gynaecological cancer; an interpretative phenomenological analysis. Complementary therapies in medicine. https://doi.org/10.1016/j.ctim.2014.12.003
"I'm 100% for it! I'm a convert!": Women's experiences of a yoga programme during treatment for gynaecological cancer; an interpretative phenomenological analysis.
Archer, Stephanie, Phillips, Elly, Montague, Jane, Bali, Anish and Sowter, Heidi M. 2015. "I'm 100% for it! I'm a convert!": Women's experiences of a yoga programme during treatment for gynaecological cancer; an interpretative phenomenological analysis. Complementary therapies in medicine. https://doi.org/10.1016/j.ctim.2014.12.003
Identification of novel candidate biomarkers of epithelial ovarian cancer by profiling the Secretomes of three-dimensional genetic models of ovarian carcinogenesis.
Lawrenson, Kate, Mhawech-Fauceglia, Paulette, Worthington, Jenny, Spindler, Tassja J., O'Brien, Darragh, Lee, Janet M., Spain, Georgia, Sharifian, Maryam, Wang, Guisong, Darcy, Kathleen M., Pejovic, Tanja, Sowter, Heidi M., Timms, John F. and Gayther, Simon A. 2014. Identification of novel candidate biomarkers of epithelial ovarian cancer by profiling the Secretomes of three-dimensional genetic models of ovarian carcinogenesis. International Journal of Cancer. https://doi.org/10.1002/ijc.29197
The Eag potassium channel as a new prognostic marker in ovarian cancer.
Asher, Viren, Khan, Raheela, Warren, Averil, Shaw, Robert, Schalkwyk, Gerhard V., Bali, Anish and Sowter, Heidi M. 2010. The Eag potassium channel as a new prognostic marker in ovarian cancer. Diagnostic pathology. https://doi.org/10.1186/1746-1596-5-78
The role of Eag and HERG channels in cell proliferation and apoptotic cell death in SK-OV-3 ovarian cancer cell line.
Asher, Viren, Warren, Averil, Shaw, Robert, Sowter, Heidi M., Bali, Anish and Khan, Raheela 2011. The role of Eag and HERG channels in cell proliferation and apoptotic cell death in SK-OV-3 ovarian cancer cell line. Cancer cell international. https://doi.org/10.1186/1475-2867-11-6